Загрузка...
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes
Site-specific delivery of chemotherapeutics specifically to neoplastic hepatocytes without affecting normal hepatocytes should be a focus for potential therapeutic management of hepatocellular carcinoma (HCC). The aptamer TLS 9a with phosphorothioate backbone modifications (L5) has not been explored...
Сохранить в:
| Опубликовано в: : | Mol Ther Nucleic Acids |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Gene & Cell Therapy
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7063179/ https://ncbi.nlm.nih.gov/pubmed/32146417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2020.01.034 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|